Vaccine trial data systematically assembled, pooled and disseminated by the Cochrane Collaboration

Author： Chuang J.H. Tsay L.W. Chen C. Jefferson T.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.16, Iss.16, 1998-10, pp. : 1487-1495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The WHO Vaccine Trial Registry

By Robertson S.E. Mayans M.V. El-Husseiny A. Clemens J.D. Ivanoff B.

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 31-41

Elsevier

Access to resources Recommend Favorite

Liposomes containing Candida albicans ribosomes as a prophylactic vaccine against disseminated candidiasis in mice

By Eckstein M. Barenholz Y. Bar L.K. Segal E.

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Early phase II trial of human rotavirus vaccine candidate RV3

By Barnes G.L. Lund J.S. Mitchell S.V. De Bruyn L. Piggford L. Smith A.L. Furmedge J. Masendycz P.J. Bugg H.C. Bogdanovic-Sakran N. Carlin J.B. Bishop R.F.

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2950-2956

Elsevier

Access to resources Recommend Favorite

Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation?

By Jaffar S. Leach A. Hall A.J. Obaro S. McAdam K.P.W.J. Smith P.G. Greenwood B.M.

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 633-640

Elsevier

Access to resources Recommend Favorite

Randomized, comparative trial of 20 g vs 40 g Engerix B vaccine in hepatitis B vaccine non-responders

By Goldwater P.N.

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 353-356

Elsevier

Access to resources Recommend Favorite